carbazilquinone has been researched along with Cell Transformation, Neoplastic in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himori, T | 1 |
| Ujiie, S | 1 |
| Mimata, Y | 1 |
| Sugiyama, Z | 1 |
| Wakui, A | 1 |
1 other study available for carbazilquinone and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Total tumor cell count and hematopoietic system of ah 109A-bearing rats treated with mitomycin C and carboquone.
Topics: Animals; Antineoplastic Agents; Azirines; Carbazilquinone; Carcinoma, Hepatocellular; Cell Transform | 1982 |